Re-invigorating rather than re-inventing the wheel: augmenting the impact of salvage autologous stem cell transplantation for multiple myeloma in the era of novel agents

被引：2
|
作者：
Cook, G. [1 ]
机构：
[1] Univ Leeds, Dept Haematol, Transplant Immunol Grp, Sect Expt Haematol,Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England
来源：
BONE MARROW TRANSPLANTATION | 2015年 / 50卷 / 10期
关键词：
HIGH-DOSE MELPHALAN; BORTEZOMIB; DEXAMETHASONE; THERAPY; PHASE-2; RELAPSE; TRIAL;
D O I：
10.1038/bmt.2015.175
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1269 / 1270
页数：2
相关论文
共 25 条
  • [21] Response Improvement Rather than Response Status after First Autologous Stem Cell Transplantation Is a Significant Prognostic Factor for Survival Benefit from Tandem Compared with Single Transplantation in Multiple Myeloma Patients
    Blocka, Joanna
    Hielscher, Thomas
    Goldschmidt, Hartmut
    Hillengass, Jens
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (07) : 1280 - 1287
  • [22] Efficacy and Survival Outcome Associated with the Use of Novel Agents and Autologous Stem Cell Transplantation in Cases of Immunoglobulin D Multiple Myeloma in Korea
    Kang, Jihoon
    Hong, Jung Yong
    Yoon, Dok Hyun
    Kim, Shin
    Lee, Kyoung Min
    Park, Jung Sun
    Park, Chan-Jeoung
    Min, Won-Ki
    Seo, Eul-Ju
    Jang, Seongsoo
    Suh, Cheolwon
    ACTA HAEMATOLOGICA, 2018, 139 (03) : 185 - 192
  • [23] Favorable prognostic impact of RAS mutation status in multiple myeloma treated with high-dose melphalan and autologous stem cell support in the era of novel agents: a single center perspective
    Gebauer, Niklas
    Biersack, Harald
    Czerwinska, Ann-Cathrin
    Schemme, Janina
    Hardel, Tim Tristan
    Bernard, Veronica
    Rades, Dirk
    Lehnert, Hendrik
    Luley, Kim Barbara
    Thorns, Christoph
    LEUKEMIA & LYMPHOMA, 2016, 57 (01) : 226 - 229
  • [24] Novel agents-based regimens as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: a meta-analysis of randomized controlled trials
    Wang, Lida
    Ran, Xuehong
    Wang, Baohong
    Sheng, Zhixin
    Liu, Liping
    HEMATOLOGICAL ONCOLOGY, 2012, 30 (02) : 57 - 61
  • [25] Improved Survival for Multiple Myeloma in Denmark Based on Autologous Stem Cell Transplantation and Novel Drug Therapy in Collaborative Trials: Analysis of Accrual, Prognostic Variables, Selection Bias, and Clinical Behavior on Survival in More Than 1200 Patients in Trials of the Nordic Myeloma Study Group
    Johnsen, Hans E.
    Klausen, Tobias W.
    Boegsted, Martin
    Lenhoff, Stig
    Gimsing, Peter
    Christiansen, Ilse
    Gedde-Dahl, Tobias
    Lindas, Roald
    Mellqvist, Ulf-Henrik
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (04) : 290 - 296
123